Perspectives in Clinical Research最新文献

筛选
英文 中文
Evaluation of patient awareness to drug treatment and self-medication practices: Unexplored dimensions in chronic heart failure management. 评估患者对药物治疗和自我药疗实践的认识:慢性心力衰竭管理中未探索的维度。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-05-29 DOI: 10.4103/picr.picr_162_24
Raakhi Kaliprasad Tripathi, Sujeet Krishna Bhilwade, Sharmila Vinayak Jalgaonkar, Dhiraj Kumar, Pramod Gitte
{"title":"Evaluation of patient awareness to drug treatment and self-medication practices: Unexplored dimensions in chronic heart failure management.","authors":"Raakhi Kaliprasad Tripathi, Sujeet Krishna Bhilwade, Sharmila Vinayak Jalgaonkar, Dhiraj Kumar, Pramod Gitte","doi":"10.4103/picr.picr_162_24","DOIUrl":"10.4103/picr.picr_162_24","url":null,"abstract":"<p><strong>Introduction: </strong>Treatment adherence is crucial in management of chronic heart failure (HF) to prevent complications (hospitalizations). Patient awareness toward drug treatment is essential to ensure adherence. In addition, there is tendency to self-medicate which can be hazardous in these patients. The present study was planned to evaluate drug treatment awareness, patient tendency to self-medicate and prescription patterns in chronic HF patients.</p><p><strong>Methodology: </strong>A cross-sectional, single-center, questionnaire-based study was conducted in the cardiology outpatient department of a tertiary care hospital from April 2021 to November 2022 after obtaining institutional ethics committee permission. Consented patients aged >18 years of either gender with confirmed diagnosis of chronic HF on stable drug treatment were included. Current prescription details were recorded, subsequently patients were administered a prevalidated drug treatment awareness (11-item, score-11) questionnaire and self-medication practice (12-item) questionnaire.</p><p><strong>Results: </strong>Two hundred and fifty-six HF patients were enrolled and the overall mean treatment awareness score was 5.06 ± 1.77 and content accuracy was poor for names of the prescribed drugs (58/256,23%), dose/frequency (20/256, 8%) and adverse effects (0). Fifty-one percent HF patients indulged in self-medication practices with most common self-medicating drugs being analgesics. The average number of drugs/encounter was 5.95 ± 1.12 and most common class was beta-blockers.</p><p><strong>Conclusion: </strong>Drug treatment awareness lacked in names, dose, frequency, and adverse effects of the prescribed drugs. Nearly 50% patients indulged in self-medication practices, maximum with analgesics. The most common drug class prescribed was beta-blockers (Metoprolol) followed by angiotensin converting enzyme inhibitors (Ramipril).</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"143-149"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pharmacoeconomic study using the willingness to pay model for postexposure prophylaxis for animal bites at a public sector tertiary referral center. 在公共部门三级转诊中心使用支付意愿模型进行动物咬伤暴露后预防的药物经济学研究。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-05-29 DOI: 10.4103/picr.picr_179_24
Roopa Parida, Nithya Jaideep Gogtay, Vijaya Laxman Chaudhari, Ananya Rakshit, Balaji Mane, Prachi V Bhoir, Vipin Subhash Mokalkar
{"title":"A pharmacoeconomic study using the willingness to pay model for postexposure prophylaxis for animal bites at a public sector tertiary referral center.","authors":"Roopa Parida, Nithya Jaideep Gogtay, Vijaya Laxman Chaudhari, Ananya Rakshit, Balaji Mane, Prachi V Bhoir, Vipin Subhash Mokalkar","doi":"10.4103/picr.picr_179_24","DOIUrl":"10.4103/picr.picr_179_24","url":null,"abstract":"<p><strong>Context: </strong>Rabies is a neglected, vaccine-preventable, zoonotic, viral disease that affecting the central nervous system. Understanding its economic burden will aid in developing strategies to reduce mortality.</p><p><strong>Aims: </strong>The aims of this study were to assess willingness to pay (WTP) for postexposure prophylaxis (PEP) for anti-rabies vaccination (ARV).</p><p><strong>Setting and design: </strong>This was a a cross-sectional, interview based, pharmacoeconomic study.</p><p><strong>Subjects and methods: </strong>After ethics approval and written informed consent, patients visiting the institute for PEP were enrolled and explained the bidding game strategy, and details of their socioeconomic strata (SES) were collected. Participants were asked regarding the WTP with a predecided starting bid amount of Indian rupees (INR) 2500/- for complete ARV. Based on their first response, this amount was either reduced or increased by INR 500/- until a final WTP reached. This was similarly done for travel and supporting medications.</p><p><strong>Statistical analysis used: </strong>Both descriptive and inferential (regression) statistics were applied. WTP was taken as the dependent variable, whereas demographic and animal bite-related parameters were taken as independent covariates. All analyses were done at 5% significance.</p><p><strong>Results: </strong>A total of <i>n</i> = 426 patients were enrolled. Of these, 255/426 (60%) patients were of Category III, whereas the remainder 171/426 (40%) were of Category II. Most of the patients (<i>n</i> = 306/426 [72%]-ARV, <i>n</i> = 270/426 [63%]-traveling and <i>n</i> = 277/426 [65%]-supporting medications) choose less than the bidding amount for all three aspects studied. Regression analysis showed that higher SES when the bite was from a dog and transdermal bites were significantly associated with a higher WTP.</p><p><strong>Conclusion: </strong>Lower socioeconomic strata are associated with lower WTP. Although this is challenging to address, raising awareness about completing vaccinations is crucial, as rabies is 100% fatal once the central nervous system is affected and clinical symptoms appear.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"156-161"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crafting an effective questionnaire: An essential prerequisite of engaging surveys. 制作有效的问卷:参与调查的必要先决条件。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-02-25 DOI: 10.4103/picr.picr_157_24
Hunny Sharma, Manisha Ruikar
{"title":"Crafting an effective questionnaire: An essential prerequisite of engaging surveys.","authors":"Hunny Sharma, Manisha Ruikar","doi":"10.4103/picr.picr_157_24","DOIUrl":"10.4103/picr.picr_157_24","url":null,"abstract":"<p><p>Questionnaires play a crucial role in biomedical research, enabling valuable data collection from individuals. However, the effectiveness of a questionnaire depends on its ability to engage respondents and gather accurate information. This manuscript delves into the intricacies of crafting an effective questionnaire, exploring the essential elements that contribute to their success and impact, and highlights the need for well-crafted questionnaires in biomedical research emphasizing the importance of maximizing respondent engagement, obtaining reliable data, enhancing data completeness, minimizing nonresponse rates and bias, and facilitating data analysis. The article further sheds light on the factors influencing questionnaire effectiveness, including clear and concise language, logical flow and structure, relevance and significance, avoidance of double-barreled and leading questions, and using balanced response options and skip questions. This narrative review examines how each factor contributes to questionnaire quality and offers examples to illustrate their importance. Moreover, it emphasizes the significance of investing time and effort in designing effective questionnaires to ensure the validity and success of biomedical research. By understanding the art of engaging surveys, researchers can optimize their data collection processes and enhance the reliability and validity of their findings.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"118-126"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The landscape of Phase IV Clinical Trials in India - A comprehensive analysis of the Clinical Trial Registry-India. 印度IV期临床试验的前景-对印度临床试验注册的综合分析。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-05-28 DOI: 10.4103/picr.picr_150_24
Bikash Ranjan Meher, Bikram Keshari Rout, Subashri Ponnusamy, Rashmi Ranjan Mohanty, Biswa Mohan Padhy
{"title":"The landscape of Phase IV Clinical Trials in India - A comprehensive analysis of the Clinical Trial Registry-India.","authors":"Bikash Ranjan Meher, Bikram Keshari Rout, Subashri Ponnusamy, Rashmi Ranjan Mohanty, Biswa Mohan Padhy","doi":"10.4103/picr.picr_150_24","DOIUrl":"10.4103/picr.picr_150_24","url":null,"abstract":"<p><strong>Purpose: </strong>Phase IV clinical studies are usually performed after a new drug obtains approval from a regulatory agency for marketing and use in the general population. There is not much information available on public platform regarding the types of contemporary Phase IV studies conducted in India. We aimed to determine the fundamental characteristics of Phase IV clinical trials using the Clinical Trials Registry-India (CTRI) registry data.</p><p><strong>Materials and methods: </strong>A comprehensive search was undertaken for the total number of Phase IV studies registered between the inception of CTRI and May 2024. Information was analyzed based on the different characteristics of the registered study like year of registration, type of study, type of intervention, type of outcome, and type of sponsorship.</p><p><strong>Results: </strong>Two hundred and thirty-eight studies fulfilling the inclusion criteria were included in the analysis. Twenty-nine (12.2%) of those were undertaken to assess only safety outcomes, 27 (11.4%) had only efficacy outcomes whereas a large number of studies (<i>n</i> = 182, 76.4%) were conducted to assess both safety as well as efficacy parameters. Almost 98% of the studies did not provide details of publication on the CTRI platform.</p><p><strong>Conclusion: </strong>Although progress has been made in the conduction of clinical research in India, there is a need to conduct more Phase IV clinical studies and provide the details of their publication on the CTRI site to enhance credibility and transparency.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"138-142"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A crucial role of on-site clinical trial monitoring: Insights from the ethics committee. 现场临床试验监测的关键作用:来自伦理委员会的见解。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-01-30 DOI: 10.4103/picr.picr_123_24
Chaitali Ashish Chindhalore, Ganesh Natthuji Dakhale, Snehalata Gajbhiye
{"title":"A crucial role of on-site clinical trial monitoring: Insights from the ethics committee.","authors":"Chaitali Ashish Chindhalore, Ganesh Natthuji Dakhale, Snehalata Gajbhiye","doi":"10.4103/picr.picr_123_24","DOIUrl":"10.4103/picr.picr_123_24","url":null,"abstract":"<p><strong>Background: </strong>On-site monitoring by the institutional ethics committee (IEC) is one of the most effective ways to ensure compliance during research conduct.</p><p><strong>Objectives: </strong>The objectives of this study were to analyze the reports of clinical trial (CT) site monitoring conducted by IEC from January 2021 to March 2024 and to assess the impact of the monitoring by analyzing compliance reports submitted by the trial site team.</p><p><strong>Methodology: </strong>A retrospective analysis of site monitoring and compliance reports was conducted after obtaining necessary approvals from IEC.</p><p><strong>Results: </strong>The present study analyzed 22 reports of site monitoring conducted from 2021 to 2024. A total of 56 deviations were observed during monitoring. The most common deviations observed were related to documentation and record-keeping (31/56). In many cases, logs were incomplete (10/56). Traveling allowance (TA) was given but receipt was not maintained (4/56). Major observed were deducting expenses of consumables from TA, not giving TA and ICF was not signed and dated by patient/LAR. Based on monitoring report, query letters were sent to respective PIs with instructions to submit explanations and compliance reports. The PIs submitted compliance report mentioning CAPA in response to deviations pointed out by ethics committee monitoring team and submitted their reports to the IEC. The percentage improvement in ethical conduct of trials was 96.42%.</p><p><strong>Conclusion: </strong>In the present study, active trial site monitoring helped the IEC to identify deviations that were impossible to identify by passive monitoring. Majority of deviations were resolved after being pointed out by IEC highlighting the importance of active monitoring. Thus, on-site CT monitoring is a critical aspect of ethical oversight, ensuring participant safety, maintaining data integrity and credibility, detecting compliance issues, and enhancing trust and transparency.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"132-137"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applied intelligence in clinical drug development: Potential benefits and emerging concerns. 应用智能在临床药物开发:潜在的好处和新出现的问题。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-05-27 DOI: 10.4103/picr.picr_37_25
Arun Bhatt
{"title":"Applied intelligence in clinical drug development: Potential benefits and emerging concerns.","authors":"Arun Bhatt","doi":"10.4103/picr.picr_37_25","DOIUrl":"10.4103/picr.picr_37_25","url":null,"abstract":"<p><p>The use of artificial intelligence (AI) technology and machine learning (ML) is growing exponentially and is moving from AI to applied intelligence. Pharma industry is actively exploring the potential use of AI tools in new product discovery and clinical development. Some of the practical applications of AI in clinical development are for improving the efficiency of enrollment, selection and stratification of participants, optimizing study treatment, enhancing compliance, data analysis, and pharmacovigilance. AI applications have been used for outcome prediction; covariate selection/confounding adjustment; anomaly detection; real-world data phenotyping; imaging, video, and voice analysis; endpoint assessment; and pharmacometric modeling in regulatory submissions. However, widespread applications of novel yet difficult-to-understand AI technology in clinical development would need balancing the benefits and risks and resolving issues of scientific validity, technical quality, and ethics. The article discusses the potential benefits and emerging concerns of applying AI in clinical drug development.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"127-131"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measuring quality of life in clinical research - Part 1. 临床研究中生活质量的测量。第1部分
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-07-08 DOI: 10.4103/picr.picr_179_25
Priya Ranganathan, Jammbe Z Musoro, C S Pramesh
{"title":"Measuring quality of life in clinical research - Part 1.","authors":"Priya Ranganathan, Jammbe Z Musoro, C S Pramesh","doi":"10.4103/picr.picr_179_25","DOIUrl":"10.4103/picr.picr_179_25","url":null,"abstract":"<p><p>Health-related quality of life (HRQOL) is increasingly being recognized as an important outcome for individuals, both as part of clinical care as well as in research, along with conventional outcomes like response or survival. HRQOL includes several domains of functioning and is complex and difficult to measure. In this series of articles, we examine the concept of HRQOL and methods to measure it.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"162-165"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A questionnaire-based study on literature searches among medical postgraduates. 基于问卷的医学研究生文献检索研究。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2024-08-07 DOI: 10.4103/picr.picr_60_24
R Yukesh, Ushakiran Prayaga
{"title":"A questionnaire-based study on literature searches among medical postgraduates.","authors":"R Yukesh, Ushakiran Prayaga","doi":"10.4103/picr.picr_60_24","DOIUrl":"10.4103/picr.picr_60_24","url":null,"abstract":"","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"166-167"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Status of registration, re-registration, and accreditation of ethics committees with Central Drugs Standard Control Organization, Department of Health Research, and National Accreditation Board for Hospitals and Healthcare Providers - An evaluation of the extent of ethics oversight in the country. 伦理委员会在中央药品标准控制组织、卫生研究部和国家医院和医疗保健提供者认证委员会的注册、再注册和认证状况——对该国伦理监督程度的评估。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-05-31 DOI: 10.4103/picr.picr_184_24
Ananya Rakshit, Karan Muzumdar, Nithya Jaideep Gogtay, Yashodhan Desai, Urmila Mukund Thatte
{"title":"Status of registration, re-registration, and accreditation of ethics committees with Central Drugs Standard Control Organization, Department of Health Research, and National Accreditation Board for Hospitals and Healthcare Providers - An evaluation of the extent of ethics oversight in the country.","authors":"Ananya Rakshit, Karan Muzumdar, Nithya Jaideep Gogtay, Yashodhan Desai, Urmila Mukund Thatte","doi":"10.4103/picr.picr_184_24","DOIUrl":"10.4103/picr.picr_184_24","url":null,"abstract":"<p><strong>Context: </strong>The \"New Drugs and Clinical Trials Rules 2019\" mandates that Ethics Committees (ECs) register with the Central Drugs Standard Control Organization (CDSCO), while ECs overseeing Postgraduate (PG) theses and academic studies must register with the Department of Health Research (DHR). National Accreditation Board for Hospitals and Healthcare Providers (NABH) accreditation of ECs is currently optional.</p><p><strong>Aim: </strong>To evaluate the current status of EC registration and re-registration with CDSCO, DHR and accreditation of NABH as a metric of ethical oversight.</p><p><strong>Subjects and methods: </strong>Data from January 1, 2019, to September 30, 2022 were collected from the organizational websites and the National Medical Commission (NMC). Registration and re-registration data for ECs were matched against the volume of studies in the Clinical Trials Registry India (CTRI), the number of ECs per state, and state populations. Descriptive and inferential statistics were applied.</p><p><strong>Results: </strong>Of the 770 ECs registered with CDSCO, 38.3% were reregistered. Of the 977 DHR-registered ECs, only 17% were re-registered. Among 370 NMC-recognized PG medical institutes, 49.72% had DHR-registered ECs. Only 13% (186/1400) ECs were NABH accredited from the overall data. A total of 14,551 regulatory studies were registered with CTRI. Among the major states (>4% of Indian population), Maharashtra had the highest percentage of CDSCO-registered ECs at 20% and accounted for 14% of regulatory studies, while states such as Bihar and West Bengal had lower percentages of both CDSCO registered ECs and regulatory studies.</p><p><strong>Conclusion: </strong>The registration, re-registration status of ECs, and accreditation are not commensurate with the quantum of regulatory and academic studies in the country.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"150-155"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Indian research trends in artificial intelligence for human health: An analysis of the WHO trial registry data. 探索印度在人工智能促进人类健康方面的研究趋势:对世卫组织试验登记数据的分析。
Perspectives in Clinical Research Pub Date : 2025-07-01 Epub Date: 2025-02-25 DOI: 10.4103/picr.picr_143_24
Himel Mondal, Ayesha Juhi, Mayank Sharma, Shreya Sharma, Pritam Kumar Chaudhary, Shaikat Mondal
{"title":"Exploring Indian research trends in artificial intelligence for human health: An analysis of the WHO trial registry data.","authors":"Himel Mondal, Ayesha Juhi, Mayank Sharma, Shreya Sharma, Pritam Kumar Chaudhary, Shaikat Mondal","doi":"10.4103/picr.picr_143_24","DOIUrl":"10.4103/picr.picr_143_24","url":null,"abstract":"","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 3","pages":"168-169"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信